The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Acute care and hydration due to chemotherapy-induced nausea and vomiting (CINV) among patients receiving NEPA prophylaxis for anthracycline + cyclophosphamide (AC).
 
Eric Roeland
Consulting or Advisory Role - AIM Specialty Health; Asahi Kasei; BASF; Helsinn Healthcare (Inst); Immuneering; Napo Pharmaceuticals; Oragenics; Pronova (Inst); Vector Oncology
 
Rudolph M. Navari
Honoraria - HERON
Travel, Accommodations, Expenses - HERON
 
Kathryn Jean Ruddy
Stock and Other Ownership Interests - Merck; Pfizer
Patents, Royalties, Other Intellectual Property - My husband is a co-inventor of technology licensed by Mayo Clinic to AliveCor (MountainView, CA), which makes a smartphone-enabled remote ECG monitoring system. (I)
 
Thomas William LeBlanc
Honoraria - Celgene; Daiichi Sankyo; Helsinn Therapeutics; Quintiles
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; AstraZeneca; Daiichi Sankyo; Helsinn Therapeutics; Heron; Medtronic; Otsuka; Pfizer; Seagen
Speakers' Bureau - Agios
Research Funding - AstraZeneca (Inst); Jazz Pharmaceuticals (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie/Genentech; Agios; Amgen; Celgene; Daiichi Sankyo; Heron; Otsuka
 
Rebecca Anne Clark-Snow
Honoraria - Merck; Tesaro
Consulting or Advisory Role - Merck; Tesaro
Speakers' Bureau - Merck
 
Rita S. Wickham
Honoraria - Genentech/Roche
Consulting or Advisory Role - Insys Therapeutics
Speakers' Bureau - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Abbvie; Insys Therapeutics
 
Gary Binder
Employment - Helsinn Therapeutics
Stock and Other Ownership Interests - Celgene
 
William L. Bailey
Employment - Helsinn Therapeutics
Stock and Other Ownership Interests - Pfizer
 
Lee S. Schwartzberg
Stock and Other Ownership Interests - Vector Oncology
Honoraria - Amgen; AstraZeneca; E.R. Squibb Sons, LLC; Genentech; Genomic Health; Helsinn Healthcare; Myriad Genetics; NanoString Technologies; Napo Pharmaceuticals; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Athenex; Biocept; bioTheranostics; Bristol-Myers Squibb; Caris Life Sciences; Coherus Biosciences; E.R. Squibb Sons, LLC; Genentech; Genomic Health; Helsinn Therapeutics; Lilly; Merck; Novartis; Pfizer; Roche; Spectrum Pharmaceuticals; Tesaro
Speakers' Bureau - Coherus Biosciences; Puma Biotechnology
Research Funding - Amgen (Inst); Bayer Health (Inst); E.R. Squibb Sons, LLC (Inst); E.R. Squibb Sons, LLC (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Helsinn Therapeutics; MedImmune (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Tesaro (Inst)